Of the 14 patients with BRCA2 LGR, 5 (5/14, 35.7%) had breast cancers, and two had ovarian cancers (2/14, 14.3%) (Supplementary Table S11). This evidence concerns the gene BRCA2 and ovarian carcinoma.